Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Archrock (AROC) Cash & Equivalents (2016 - 2025)

Archrock (AROC) has disclosed Cash & Equivalents for 17 consecutive years, with $1.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash & Equivalents fell 64.86% to $1.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.6 million, a 64.86% decrease, with the full-year FY2025 number at $1.6 million, down 64.86% from a year prior.
  • Cash & Equivalents was $1.6 million for Q4 2025 at Archrock, down from $4.1 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $5.9 million in Q2 2025 to a low of $482000.0 in Q3 2023.
  • A 5-year average of $2.5 million and a median of $1.9 million in 2021 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: plummeted 76.4% in 2023, then soared 677.8% in 2024.
  • Archrock's Cash & Equivalents stood at $1.6 million in 2021, then decreased by 0.19% to $1.6 million in 2022, then fell by 14.56% to $1.3 million in 2023, then surged by 230.34% to $4.4 million in 2024, then plummeted by 64.86% to $1.6 million in 2025.
  • Per Business Quant, the three most recent readings for AROC's Cash & Equivalents are $1.6 million (Q4 2025), $4.1 million (Q3 2025), and $5.9 million (Q2 2025).